Table 2.

Patient characteristics

CharacteristicNo. patients
Received treatment18
Median age, y (range)56 (34-76)
Race
    Caucasian17 (94.4%)
    Asian1 (5.6%)
Eastern Cooperative Oncology Group (ECOG) performance status
    011 (61.1%)
    16 (33.3%)
    Unknown1 (5.6%)
Estrogen receptor
    Positive7 (38.9%)
    Negative5 (27.8%)
    Unknown6 (33.3%)
Progesterone receptor
    Positive6 (33.3%)
    Negative6 (33.3%)
    Unknown6 (33.3%)
HER-2/neu
    1+6 (33.3%)
    2+3 (16.7%)
    3+9 (50%)
Prior chemotherapy for metastatic disease
    Yes17 (94.4%)
    No1 (5.6%)
Median time between last chemotherapy administration and first infusion of lapuleucel-T, d (range), n = 17148 (39-755)
Prior trastuzumab
    Yes9 (50%)
    No9 (50%)
Prior hormonal therapy
    Yes7 (38.9%)
    No11 (61.1%)
Prior radiation therapy
    Yes11 (61.1%)
    No7 (38.9%)